Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
In non-endemic settings, transfusion-transmitted malaria (TTM) is rare but potentially fatal and becoming more common with globalization. We present two pediatric cases that demonstrate donor screening using questionnaires is subject to error and that TTM should be considered with fever following numerous transfusions in children, particularly sickle cell patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719612 | PMC |
| http://dx.doi.org/10.1093/jpids/piab083 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Seroprevalence of transfusion-transmitted infections among blood donors in India: A systematic review and meta-analysis.
Vox Sang
August 2025
Sanquin Blood Supply Foundation, Jon J van Rood Centre for Clinical Transfusion Research, The Netherlands.
Background And Objectives: Blood transfusion is essential in healthcare but carries inherent risks of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), syphilis and malaria transmission. National sero-epidemiology data on major transfusion-transmitted infections (TTI) in blood donors are lacking in India. This review aimed to estimate the prevalence of TTI in India, examine zonal variations, assess donor demographics and testing methodologies and analyse prevalence trends to further provide recommendations for blood safety.
View Article and Find Full Text PDFPrevalence and trends of transfusion transmitted infections among blood donors in a tertiary care hospital of Assam.
Sci Rep
August 2025
Guwahati Neurological Research Centre Institute of Medical Science, North Guwahati, Assam, 781031, India.
The overall prevalence of transfusion-transmissible infections (TTIs) in India is 1.58%, while in Assam, it stands at 1.2%.
View Article and Find Full Text PDFCD47-mediated selective accumulation of mature Ly49h+ NK cells to the brain associates with the pathogenesis of cerebral malaria in mice.
J Immunol
August 2025
Division of Emerging and Transfusion Transmitted Diseases, U.S. Food and Drug Administration, Silver Spring, MD, United States.
CD47 is an antiphagocytic ("don't eat me") signal expressed on all cells that inhibits programmed cell removal of self, and loss of this molecule by aging erythrocytes is associated with increased susceptibility to clearance by macrophages. Previously, we have demonstrated that absence of CD47 confers resistance to infection with nonlethal murine malaria Plasmodium yoelii 17XNL. Furthermore, CD47 blockade with an anti-CD47 monoclonal antibody promotes survival and reduces pathologic features of experimental cerebral malaria (ECM) during infection with lethal murine malaria P.
View Article and Find Full Text PDFTransfusion-transmitted spp. infections and safety challenges for malaria in the Indian subcontinent: a systematic review.
Lancet Reg Health Southeast Asia
September 2025
Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067, India.
Blood transfusion is a globally life-saving intervention, but blood-borne pathogens can threaten its effectiveness. While blood bags are systematically screened for viral and bacterial pathogens, parasite infections are generally overlooked. In this review, we analysed the current literature on transfusion-transmitted malaria (TTM) in India over the past five decades.
View Article and Find Full Text PDFPrevalence of Transfusion-Transmitted Infections and Its Association With Blood Groups Among Blood Donors at the Blood Bank of a Tertiary Care Center.
Cureus
June 2025
Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, IND.
Background Safe blood transfusion remains a challenge, and transmission of infections is always a concern. The detection of infectious diseases in blood donors ensures the safety of blood transfusion. Another challenge is the differences in blood group antigens due to the ability of clinically significant antibodies to cause adverse reactions.
View Article and Find Full Text PDF